Search Results - "MARIETTE, XAVIER"
-
1
B cells in the pathogenesis of primary Sjögren syndrome
Published in Nature reviews. Rheumatology (01-03-2018)“…Key Points Genetic risk factors associated with primary Sjögren syndrome (pSS) can promote B cell activation, as can epigenetic changes, which can sometimes…”
Get full text
Journal Article -
2
Systemic and organ-specific immune-related manifestations of COVID-19
Published in Nature reviews. Rheumatology (01-06-2021)“…Immune-related manifestations are increasingly recognized conditions in patients with COVID-19, with around 3,000 cases reported worldwide comprising more than…”
Get full text
Journal Article -
3
Sjögren Syndrome‐associated lymphomas: an update on pathogenesis and management
Published in British journal of haematology (01-02-2015)“…Summary Primary Sjögren Syndrome (pSS) is an autoimmune disease associated with an increased risk of lymphoma. Lymphomas complicating pSS are mostly low‐grade…”
Get full text
Journal Article -
4
Current and future therapies for primary Sjögren syndrome
Published in Nature reviews. Rheumatology (01-08-2021)“…Primary Sjögren syndrome (pSS) is a systemic autoimmune disease that is characterized by a triad of symptoms that affect all patients (dryness, pain and…”
Get full text
Journal Article -
5
Lymphomas complicating primary Sjögren's syndrome: from autoimmunity to lymphoma
Published in Rheumatology (Oxford, England) (02-08-2021)“…Lymphoma development is the most serious complication of SS and the main factor impacting on mortality rate in patients with this condition. Lymphomas in SS…”
Get full text
Journal Article -
6
Chronic inflammatory arthritis following checkpoint inhibitor therapy for cancer: game changing implications
Published in Annals of the rheumatic diseases (01-03-2020)Get more information
Journal Article -
7
Immune-related adverse events of checkpoint inhibitors
Published in Nature reviews. Disease primers (07-05-2020)“…Cancer immunotherapies have changed the landscape of cancer treatment during the past few decades. Among them, immune checkpoint inhibitors, which target PD-1,…”
Get full text
Journal Article -
8
Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study
Published in Annals of the rheumatic diseases (01-02-2018)“…There is a need for effective and safe treatment during pregnancy in women with chronic inflammatory diseases. This study evaluated placental transfer of…”
Get more information
Journal Article -
9
Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials
Published in Annals of the rheumatic diseases (01-07-2017)“…Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA). We report an integrated safety summary of tofacitinib from two…”
Get more information
Journal Article -
10
Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment
Published in Annals of the rheumatic diseases (01-10-2017)“…Immune checkpoint inhibitors (ICIs) targeting cytotoxic T-lymphocyte-associated protein 4 and programmed cell death protein 1 (PD-1) have demonstrated improved…”
Get more information
Journal Article -
11
Monocyte/Macrophage Abnormalities Specific to Rheumatoid Arthritis Are Linked to miR-155 and Are Differentially Modulated by Different TNF Inhibitors
Published in The Journal of immunology (1950) (01-10-2019)“…Proinflammatory macrophages and miR-155 are increased in patients with rheumatoid arthritis (RA). We studied membrane TNF (mTNF) expression on blood monocytes,…”
Get full text
Journal Article -
12
EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome
Published in Annals of the rheumatic diseases (01-06-2010)“…To develop a disease activity index for patients with primary Sjögren's syndrome (SS): the European League Against Rheumatism (EULAR) Sjögren's syndrome…”
Get more information
Journal Article -
13
Clonal CD8 + T-cell expansion is associated with complete response to elranatamab in refractory multiple myeloma
Published in Haematologica (Roma) (01-09-2024)Get full text
Journal Article -
14
Interferon signature in systemic autoimmune diseases: what does it mean?
Published in Rheumatic & musculoskeletal diseases open (01-12-2022)“…The first description of the involvement of interferons (IFN) in systemic autoimmune diseases (AID) dates back more than 40 years.1 IFNs play a crucial role in…”
Get full text
Journal Article -
15
Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements
Published in Rheumatology (Oxford, England) (01-12-2015)“…To reach a European consensus on the definition and characterization of the main organ-specific extraglandular manifestations in primary SS. The EULAR-SS Task…”
Get full text
Journal Article Conference Proceeding -
16
Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force
Published in Annals of the rheumatic diseases (01-06-2016)“…There is convincing evidence for the known and unambiguously accepted beneficial effects of glucocorticoids at low dosages. However, the implementation of…”
Get more information
Journal Article -
17
Cytometry by time-of-flight immunophenotyping identifies a blood Sjögren's signature correlating with disease activity and glandular inflammation
Published in Journal of allergy and clinical immunology (01-06-2016)“…Background Mass cytometry has recently emerged as a promising tool for clinical research. However, few studies have demonstrated its benefit for patient…”
Get full text
Journal Article -
18
Immune interventions in COVID-19: a matter of time?
Published in Mucosal immunology (01-02-2022)“…As the COVID-19 pandemic is still ongoing, and considering the lack of efficacy of antiviral strategies to this date, and the reactive hyperinflammation…”
Get full text
Journal Article -
19
Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI)
Published in Annals of the rheumatic diseases (01-05-2015)“…To validate the two recently developed disease activity indexes for assessment of primary Sjögren's syndrome (SS): the European League Against Rheumatism…”
Get more information
Journal Article -
20
Role of good oral hygiene on clinical evolution of rheumatoid arthritis: a randomized study nested in the ESPOIR cohort
Published in Rheumatology (01-05-2020)“…Abstract Objective There is a relationship between RA and periodontal disease. We aimed to investigate if a good oral hygiene could improve activity of RA…”
Get full text
Journal Article